Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway

Nimesh Mody, J Leitch, C Armstrong, J Dixon, P Cohen

Research output: Contribution to journalArticle

217 Citations (Scopus)

Abstract

Antibodies that recognise the active phosphorylated forms of mitogen-activated protein kinase (MAPK) kinase 5 (MKK5) and extracellular signal-regulated kinase 5 (ERK5) in untransfected cells have been exploited to show that the epidermal growth factor (EGF)-induced activation of MKK5 and ERK5 occurs subsequent to the activation of ERK1 and ERK2 in HeLa cells. The drugs U0126 and PD184352, which prevent the activation of MKK1 (and hence the activation of ERK1/ERK2), also prevent the activation of MKK5, although higher concentrations are required. Our studies define physiological targets of the MKK5/ERK5 pathway as proteins whose phosphorylation is largely prevented by 10 microM PD184352, but unaffected by 2 microM PD184352. Surprisingly, 2 microM PD184352 prolongs the activation of MKK5 and ERK5 induced by EGF or H(2)O(2), indicating negative control of the MKK5/ERK5 pathway by the classical MAPK cascade. Our results also indicate that ERK5 is not a significant activator of MAPK-activated protein kinase-1/RSK in HeLa cells.
Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalFEBS Letters
Volume502
Issue number1-2
Early online date4 Jul 2001
Publication statusPublished - 27 Jul 2001

Keywords

  • Amino Acid Sequence
  • Animals
  • Benzamides
  • Butadienes
  • Enzyme Activation
  • Enzyme Inhibitors
  • Flavonoids
  • Hela Cells
  • Humans
  • MAP Kinase Signaling System
  • Mitogen-Activated Protein Kinase 7
  • Mitogen-Activated Protein Kinase Kinases
  • Mitogen-Activated Protein Kinases
  • Molecular Sequence Data
  • Nitriles
  • Phosphorylation
  • Sheep
  • Mitogen-activated protein kinase
  • Mitogen-activated protein kinase kinase 5
  • Extracellular signal-regulated kinase 5
  • BMK1
  • PD184352

Fingerprint Dive into the research topics of 'Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway'. Together they form a unique fingerprint.

  • Cite this

    Mody, N., Leitch, J., Armstrong, C., Dixon, J., & Cohen, P. (2001). Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Letters, 502(1-2), 21-24.